Powerlifting athlete suspended for presence of 11 banned substances
published on 31 May 2017
31 May 2017
The Canadian Centre for Ethics in Sport (CCES) announced today that Thomas Jamael, a powerlifting athlete, received a sanction of four years for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on February 11, 2017, revealed the presence of nandrolone, testosterone, methandienone, oxandrolone, oxymetholone, clostebol, boldenone and drostanolone (S.1 Anabolic Agents), tamoxifen and letrozole (S.4 Hormone and Metabolic Modulators), and cannabis (S.8 Cannabinoids).
In accordance with the Canadian Anti-Doping Program (CADP), if an athlete does not engage in the results process, the anti-doping rule violation and sanction are confirmed by way of a deemed waiver. Since Mr. Jamael did not engage in the results process, the violation was confirmed and a sanction was imposed starting on April 20, 2017. The athlete, who resides in Sydney, Nova Scotia, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, until April 19, 2021.
In compliance with rule 7.10 of the CADP, a copy of the CCES’ file outcome summary can be found at www.cces.ca/sanctionreg.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.
- Tags: Anti-Doping | Canadian Centre for Ethics in Sport (CCES) | Governance | Powerlifting | Regulation